1. Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions. (26th October 2016) Authors: Vultaggio, A; Petroni, G; Pratesi, S; Nencini, F; Cammelli, D; Milla, M; Prignano, F; Annese, V; Romagnani, S; Maggi, E; Matucci, A Journal: Clinical and experimental immunology Issue: Volume 186:Number 3(2016:Dec.) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group. (25th August 2017) Authors: Jolles, S; Sánchez-Ramón, S; Quinti, I; Soler-Palacín, P; Agostini, C; Florkin, B; Couderc, L-J; Brodszki, N; Jones, A; Longhurst, H; Warnatz, K; Haerynck, F; Matucci, A; de Vries, E Journal: Clinical and experimental immunology Issue: Volume 190:Number 2(2017:Nov.) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗